聚合脂质体的emtricitabine采用修饰的pullulan-一个尝试减少相关的肝毒性尝试
Sayani Bhattacharyya1, Lahari R1, Ranganath Mk2
1Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru, Karnataka, India.
Journal of liposome research
|July 1, 2024
概括
修改后的基于普鲁兰的聚合物脂质体有效地输送emtricitabine (FTC),降低毒性. 这种新的配方有望通过改善药物输送和减轻肝损伤等副作用来实现更安全的艾滋病毒预防.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 生物材料是一种生物材料.
背景情况:
- 埃姆特里西塔宾 (FTC) 是BCS I类药物,对于预防艾滋病毒至关重要.
- 高溶解度的FTC导致严重的肝毒性和乳酸化.
- 需要新的药物输送系统来减轻FTC的不良影响.
研究的目的:
- 开发和评估改性普鲁兰基聚合物脂质体,用于输送emtricitabine (FTC).
- 与纯药物相比,评估这些新型脂质体的安全性和有效性.
- 克服与传统FTC管理相关的局限性.
主要方法:
- 经过修改的普鲁兰用胆固醇和酸无水化物合成.
- 封装FTC的聚合脂质体是使用大豆脂胆和胆固醇制备的.
- 配方的特点是药物捕获,颗粒大小和形态.
- 为了评估药物释放和安全性,进行了体外,体外和体内研究.
主要成果:
- 谱分析证实了修改后的pullulan的成功合成.
- 所有脂质体配方都表现出高的药物捕获效率.
- 在体外和体外研究表明药物释放受控.
- 在小鼠体内实验表明,对血液学参数和肝功能没有不良影响.
- 细胞毒性和组织病理学研究证实了该配方与纯FTC相比的安全性.
结论:
- 修改后的基于普鲁兰的聚合物脂质体代表了对恩特里西塔 (FTC) 的安全有效的输送系统.
- 这种方法成功地克服了FTC的局限性,包括与之相关的毒性.
- 开发的脂质体具有改善艾滋病毒预防策略的巨大潜力.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


